We are live on
!
Find out more
TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$4.08B
1-Year Est. Return
58.77%
This Fund
S&P 500
This Quarter
Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
(+271%)
Cap. Flow
+$1.53B
Cap. Flow
% of AUM
16.94%
Top 10 Holdings %
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$487M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$48.2M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$29.4M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$28.9M |
| 5 |
Microsoft
MSFT
|
+$27.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$51.8M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$38.5M |
| 3 |
Direxion Daily Semiconductor Bull 3X ETF
SOXL
|
+$32.6M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$21M |
| 5 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$16.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.25% |
| 2 | Industrials | 4.6% |
| 3 | Consumer Discretionary | 4.31% |
| 4 | Healthcare | 4.26% |
| 5 | Financials | 3.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LCI
2301
DELISTED
Lannett Company, Inc.
LCI
| $263K | ﹤0.01% |
10,748
+7,356
| +217% | +$174K |
|
|
CCRN
2302
DELISTED
Cross Country Healthcare
CCRN
| $262K | ﹤0.01% |
40,470
+30,045
| +288% | +$190K |
|
2303
1-800-Flowers.com
FLWS
$261M
| $262K | ﹤0.01% |
10,532
-4,927
| -32% | -$130K |
|
|
NOVA
2304
DELISTED
Sunnova Energy
NOVA
| $262K | ﹤0.01% |
8,620
+1,770
| +26% | +$42K |
|
2305
QCR Holdings
QCRH
$1.75B
| $262K | ﹤0.01% |
9,576
+7,668
| +402% | +$226K |
|
|
LOVE
2306
LoveSac
LOVE
$258M
| $261K | ﹤0.01% |
9,437
+7,660
| +431% | +$218K |
|
|
MOFG
2307
DELISTED
MidWestOne Financial Group
MOFG
| $261K | ﹤0.01% |
14,615
+11,875
| +433% | +$224K |
|
2308
Invesco S&P 500 Low Volatility ETF
SPLV
$7.22B
| $261K | ﹤0.01% |
4,872
-10,370
| -68% | -$550K |
|
2309
Vipshop
VIPS
$6.8B
| $261K | ﹤0.01% |
16,661
-12,140
| -42% | -$238K |
|
|
AMAG
2310
DELISTED
AMAG Pharmaceuticals
AMAG
| $261K | ﹤0.01% |
27,672
+18,619
| +206% | +$177K |
|
|
JCAP
2311
DELISTED
Jernigan Capital, Inc.
JCAP
| $261K | ﹤0.01% |
15,215
+12,656
| +495% | +$203K |
|
2312
IES Holdings
IESC
$14.9B
| $260K | ﹤0.01% |
8,190
+5,728
| +233% | +$157K |
|
2313
Limoneira
LMNR
$250M
| $260K | ﹤0.01% |
18,195
+14,837
| +442% | +$213K |
|
|
ZNGA
2314
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $260K | ﹤0.01% |
28,560
+24,317
| +573% | +$226K |
|
2315
Anavex Life Sciences
AVXL
$303M
| $259K | ﹤0.01% |
56,897
+46,566
| +451% | +$200K |
|
2316
Element Solutions
ESI
$9.51B
| $259K | ﹤0.01% |
24,702
+21,186
| +603% | +$232K |
|
|
GDEN
2317
DELISTED
Golden Entertainment
GDEN
| $259K | ﹤0.01% |
18,693
+14,973
| +403% | +$168K |
|
2318
Powell Industries
POWL
$7.43B
| $259K | ﹤0.01% |
32,226
+25,992
| +417% | +$231K |
|
|
FLNA
2319
Filana Therapeutics
FLNA
$45.7M
| $259K | ﹤0.01% |
22,513
+21,362
| +1,856% | +$96.3K |
|
2320
Hanover Insurance
THG
$7.77B
| $259K | ﹤0.01% |
2,784
-4,213
| -60% | -$418K |
|
|
NEED
2321
DELISTED
Direxion Daily Consumer Staples Bull 3X Shares
NEED
| $259K | ﹤0.01% |
8,752
-1,827
| -17% | -$51.3K |
|
2322
Brown-Forman Class A
BF.A
$13.1B
| $258K | ﹤0.01% |
3,757
+3,655
| +3,583% | +$238K |
|
2323
Capital City Bank Group
CCBG
$898M
| $258K | ﹤0.01% |
13,740
+11,321
| +468% | +$222K |
|
2324
OR Royalties Inc
OR
$6.15B
| $258K | ﹤0.01% |
21,974
+21,608
| +5,904% | +$251K |
|
|
PDM
2325
Piedmont Realty Trust
PDM
$1.2B
| $258K | ﹤0.01% |
19,001
+9,826
| +107% | +$152K |
|
Similar funds
CA
ICP
AP
BWA
JSW
SP
GCM
ZP
Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review
As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.
- Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
- Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
- Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
- Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
- Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
- Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
- Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.